These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 8771910)

  • 21. Leptin regulation of islet amyloid polypeptide secretion from mouse pancreatic islets.
    Karlsson E; Stridsberg M; Sandler S
    Biochem Pharmacol; 1998 Nov; 56(10):1339-46. PubMed ID: 9825733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Islet amyloid polypeptide response to glucose, insulin, and somatostatin analogue administration.
    Mitsukawa T; Takemura J; Asai J; Nakazato M; Kangawa K; Matsuo H; Matsukura S
    Diabetes; 1990 May; 39(5):639-42. PubMed ID: 1970540
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of islet amyloid polypeptide in human pancreatic islets.
    Novials A; Sarri Y; Casamitjana R; Rivera F; Gomis R
    Diabetes; 1993 Oct; 42(10):1514-9. PubMed ID: 8375592
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma islet amyloid polypeptide levels in obesity, impaired glucose tolerance and non-insulin-dependent diabetes mellitus.
    Enoki S; Mitsukawa T; Takemura J; Nakazato M; Aburaya J; Toshimori H; Matsukara S
    Diabetes Res Clin Pract; 1992 Jan; 15(1):97-102. PubMed ID: 1541241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic exposure of cultured rat pancreatic islets to elevated concentrations of islet amyloid polypeptide (IAPP) causes a decrease in islet DNA content and medium insulin accumulation.
    Sandler S; Stridsberg M
    Regul Pept; 1994 Sep; 53(2):103-9. PubMed ID: 7831499
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased plasma levels of islet amyloid polypeptide in patients with primary hyperparathyroidism.
    Valdermarsson S; Leckström A; Westermark P; Bergenfelz A
    Eur J Endocrinol; 1996 Mar; 134(3):320-5. PubMed ID: 8616529
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decrease of stimulated amylin release precedes impairment of insulin secretion in type II diabetes.
    Ludvik B; Lell B; Hartter E; Schnack C; Prager R
    Diabetes; 1991 Dec; 40(12):1615-9. PubMed ID: 1756902
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic low dose islet amyloid polypeptide infusion reduces food intake, but does not influence glucose metabolism, in unrestrained conscious rats: studies using a novel aortic catheterization technique.
    Arnelo U; Permert J; Larsson J; Reidelberger RD; Arnelo C; Adrian TE
    Endocrinology; 1997 Oct; 138(10):4081-5. PubMed ID: 9322915
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of insulin secretion, but normal peripheral insulin sensitivity, in a patient with a malignant endocrine pancreatic tumour producing high amounts of an islet amyloid polypeptide-like molecule.
    Stridsberg M; Berne C; Sandler S; Wilander E; Oberg K
    Diabetologia; 1993 Sep; 36(9):843-9. PubMed ID: 8405756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The human serum protein C4b-binding protein inhibits pancreatic IAPP-induced inflammasome activation.
    Kulak K; Westermark GT; Papac-Milicevic N; Renström E; Blom AM; King BC
    Diabetologia; 2017 Aug; 60(8):1522-1533. PubMed ID: 28500395
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beta-cell activity and hepatic insulin extraction following dexamethasone administration in healthy subjects.
    Kautzky-Willer A; Thomaseth K; Clodi M; Ludvik B; Waldhäusl W; Prager R; Pacini G
    Metabolism; 1996 Apr; 45(4):486-91. PubMed ID: 8609836
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo glucose-stimulated amylin secretion is increased in nondiabetic patients with pancreatic cancer.
    Mäkimattila S; Hietaniemi K; Kiviluoto T; Timonen T; Yki-Järvinen H
    Metabolism; 2001 Sep; 50(9):1036-42. PubMed ID: 11555835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypersecretion of IAPP from the islets of VMH-lesioned rats and obese Zucker rats.
    Tokuyama Y; Kanatsuka A; Ohsawa H; Yamaguchi T; Makino H; Yoshida S; Nagase H; Inoue S
    Diabetes Res Clin Pract; 1992 Jan; 15(1):23-9. PubMed ID: 1541231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transgenic overexpression of human islet amyloid polypeptide inhibits insulin secretion and glucose elimination after gastric glucose gavage in mice.
    Ahrén B; Oosterwijk C; Lips CJ; Höppener JW
    Diabetologia; 1998 Nov; 41(11):1374-80. PubMed ID: 9833947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Islet amyloid polypeptide (amylin) does not seem to be directly involved in the development of gestational diabetes mellitus.
    Grigorakis SI; Alevizaki M; Rapti E; Anastasiou E; Alevizaki CC; Souvatzoglou A
    Gynecol Obstet Invest; 1997; 44(1):6-10. PubMed ID: 9251946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dissociated insulin and islet amyloid polypeptide secretion from isolated rat pancreatic islets cocultured with human pancreatic adenocarcinoma cells.
    Wang F; Adrian TE; Westermark G; Gasslander T; Permert J
    Pancreas; 1999 May; 18(4):403-9. PubMed ID: 10231847
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Basal and stimulated plasma levels of pancreatic amylin indicate its co-secretion with insulin in humans.
    Hartter E; Svoboda T; Ludvik B; Schuller M; Lell B; Kuenburg E; Brunnbauer M; Woloszczuk W; Prager R
    Diabetologia; 1991 Jan; 34(1):52-4. PubMed ID: 2055340
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Islet amyloid polypeptide: mechanisms of amyloidogenesis in the pancreatic islets and potential roles in diabetes mellitus.
    Johnson KH; O'Brien TD; Betsholtz C; Westermark P
    Lab Invest; 1992 May; 66(5):522-35. PubMed ID: 1573849
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Islet amyloid polypeptide: a review of its biology and potential roles in the pathogenesis of diabetes mellitus.
    O'Brien TD; Butler PC; Westermark P; Johnson KH
    Vet Pathol; 1993 Jul; 30(4):317-32. PubMed ID: 8212454
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Islet amyloid polypeptide in the islets of Langerhans: friend or foe?
    Gebre-Medhin S; Olofsson C; Mulder H
    Diabetologia; 2000 Jun; 43(6):687-95. PubMed ID: 10907112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.